Improvements in medical imaging technology, such as mobile imaging devices and 3-D ultrasonic holography, which do not use harmful radiation, have resulted in enhanced diagnosis and treatment methods for patients. As pediatric patients are more susceptible to radiation than adults, manufacturers are concentrating on creating X-ray imaging devices that are safer and more effective, with lower levels of harmful radiation specifically designed for this age group, as encouraged by the U.S. FDA. Additionally, companies are partnering with IT firms to develop software that can improve diagnostic and treatment techniques, including quantitative analysis tools and advanced visualization. These technologies, including apps that are linked to medical imaging devices, are expected to provide a competitive advantage to manufacturers in the medical imaging devices market. For example, the University of Pittsburgh Medical Center (UPMC) is collaborating with GE Health Cloud to develop a new cloud system that can manage files from ultrasound machines, computed tomography (CT) scanners, magnetic resonance imaging (MRIs), and other imaging devices.
The leading companies, including top 10 participants based on their 2016 revenue – Shimadzu Corporation, Siemens AG, Philips Healthcare, Carestream Health, Samsung Medison, Fujifilm Holdings Corporation, Hologic, Inc., GE Healthcare, Hitachi Ltd, and Toshiba Medical Systems Corporation are operating in the market for medical imaging devices.
Ask Us to Get Your Sample Copy Of The Report, Covering TOC and Regional Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/1125
Philips Healthcare
Company Description – As a subsidiary of Koninklijke Philips, Philips Healthcare manufactures and sells a diverse range of products, such as healthcare IT solutions, patient monitoring equipment, cardiac devices, and diagnostic imaging systems.
Major highlights – The company is striving to increase its market share and profitability in the global medical imaging devices market by offering products in the oncology and radiology segments, which consist of smart devices, software, and services. Additionally, the company is placing emphasis on the development of ultrasound products for general imaging and gynecology/obstetrics. In 2014, the company achieved U.S. FDA approval for its spectral imaging system, the IQon Spectral CT, which has become a leading, high-quality medical imaging system. The Radiological Society of North America conducted a study in 2013 that compared the Philips IQon Spectral CT with traditional imaging methods and found that the IQon Spectral CT system provided enhanced diagnosis in up to 70% of cases compared to traditional imaging methods. In August 2019, Koninklijke Philips N.V. acquired the Healthcare Information Systems (HCIS) business of Carestream Health Inc. and merged it into Philips’ Enterprise Diagnostic Informatics business.
GE Healthcare
Company Description – GE Healthcare, a subsidiary of GE Electrical, is involved in producing medical imaging systems, cardiac devices, and patient monitoring devices. The company provides a broad spectrum of products and services such as diagnostics and patient monitoring, software and IT, biopharmaceutical manufacturing technologies for drug discovery, and solutions for enhancing performance.
Major highlights – In 2016, the healthcare systems, including diagnostic imaging and clinical systems, contributed to 70% of GE Healthcare’s revenue, with the U.S. and Europe making up 66% of the healthcare revenue. To expand their product offerings, the company is prioritizing the development of mobile- and cloud-based apps. For example, the GE Health Cloud and apps were introduced in the United States in 2015, with the new cloud system aiming to connect over 500,000 GE imaging machines and assist clinicians in achieving better patient results. In September 2015, GE Healthcare Canada teamed up with the Biomedical Translational Imaging Centre (BIOTIC) to establish a technology commercialization program in Halifax to advance software technology in medical imaging.
Siemens AG
Company Description – Siemens Healthcare is a healthcare and medical technology firm that is a subsidiary of Siemens. It produces therapeutic and clinical diagnostic systems. The Healthineers division of the company is divided into six business segments, which include diagnostic imaging, laboratory diagnostics, advanced therapies, ultrasound, point-of-care diagnostics, and services.
Major highlights – The company is prioritizing research and development efforts aimed at incorporating state-of-the-art medical technologies for in vitro diagnosis. Healthineers’ increase in profits was primarily due to their diagnostic imaging business, which made up the biggest portion of their overall profit. In September of 2019, Siemens Healthineers allocated $2.7 million towards expanding their medical imaging manufacturing plant located in India.
Carestream Health
Company Description: Carestream Health offers healthcare information technology solutions and medical imaging products, including radiography systems, analog X-ray, cone beam CT, healthcare IT solutions, and ultrasound.
Major highlights – Health Canada granted a license to Carestream Touch Prime Ultrasound Systems in 2016, which enables wireless connectivity and quick transfer of images and data. It also enhances access to crucial imaging information for clinicians. Additionally, the system has the ability to penetrate deep into the abdomen, making it useful for imaging overweight and obese patients. The company is working on developing 3D and 4D technologies to improve the quality of images for better diagnostics in radiology. Furthermore, Carestream’s OnSight 3D Extremity System that employs cone beam CT (CBCT) technology received U.S. FDA 510(k) clearance in 2016. In comparison to traditional CT systems, the system reduces the dose and provides high-resolution 3D images.
𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐔𝐩 𝐓𝐨 𝟐𝟓% 𝐎𝐅𝐅 @ https://www.coherentmarketinsights.com/insight/buy-now/1125
Fujifilm Holdings Corporation
Company Description: – Fujifilm, along with its affiliated companies, is involved in the production and distribution of diverse information solutions and medical imaging products. Its healthcare division specializes in providing medical imaging systems.
Major highlights – The healthcare division experienced an increase in revenue due to the sales of the CALNEO series, which is a DR cassette digital X-ray imaging diagnostic system, as well as a digital mammography system. In January 2017, Fujifilm Medical Systems obtained pre-marketing approval from the U.S. FDA for Digital Breast Tomosynthesis (DBT). This is an optional software upgrade for the Aspire Cristalle digital mammography system. By incorporating DBT, radiologists utilizing the Aspire Cristalle system can improve clinical efficiency and diagnostic accuracy, surpassing the capabilities of full-field digital mammography (FFDM) alone. Fujifilm Medical Systems introduced FCT Embrace in 2018, a computed tomography (CT) imaging unit designed for oncology and radiology applications with a wide bore and available in 64 or 128 slice configuration. In July 2019, FUJIFILM Medical Systems U.S.A. and FUJIFILM New Development U.S.A. established a new medical device headquarters in Lexington, Massachusetts to bring advanced technologies to the market.
Table of Contents with Major Points:
Executive Summary
- Introduction
- Key Findings
- Recommendations
- Definitions and Assumptions
Executive Summary
Market Overview
- Definition of Medical Imaging Devices Market
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Trends and Developments
Key Insights
- Key Emerging Trends
- Key Developments Mergers and Acquisition
- New Product Launches and Collaboration
- Partnership and Joint Venture
- Latest Technological Advancements
- Insights on Regulatory Scenario
- Porters Five Forces Analysis
Qualitative Insights Impact of COVID-19 on Global Medical Imaging Devices Market
- Supply Chain Challenges
- Steps taken by Government/Companies to overcome this impact
- Potential opportunities due to COVID-19 outbreak
Conclusion
Appendix
- Data Sources
- Abbreviations
- Disclaimer
TOC Continued…!
Why Choose Coherent Market Insights?
☛ Identified business opportunities – Our market research report can be used to analyze potential markets and new products. It can give information about customer needs, preferences, and attitudes. Also, it compare products and services.
☛ A clear understanding of your customers – A market report gives company’s marketing department an in-depth picture about customers’ needs and wants. This knowledge can be used to improve products, prices, and advertising.
☛ Clear data-driven insights – Our Market research encompasses a wide range of activities, from determining market size and segment to forecasting demand, and from identifying competitors to monitoring pricing. All of these are quantified and measurable which means that gives you a clear path for building unique decisions based on numbers.
Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/1125
Explore More Related Insights:
- Dental Turbine Market
- Vascular Embolization Market
- Vision Impairment Market
- Bioresorbable Implants Market
- ECG Sensor Patch Market
- Portable X-ray Devices Market
- U.S. Hospital Emergency Department Market
- Neurofeedback Market
- Bone Glue Market
- Anesthesia Gas Scavenging System Market
- Laser Indirect Ophthalmoscope Market
- Antimicrobial Catheter Market
- Intra-abdominal Pressure Measurement Devices Market
- India Advanced Wound Care Management Market
- Microkeratome Market
- Visual Impairment Market
- Kidney Transplant Market
- Laparoscopic Power Morcellators Market
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Mr Shah
Coherent Market Insights
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837